# Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue

> **NCT00144235** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 412 (—)

## Conditions studied

- Mental Competency
- Mental Fatigue

## Interventions

- **DRUG:** Pharmaton PHL 00749
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00144235
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 412 (—)
- **Last updated:** 2013-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144235, "Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00144235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*